Clinical trial
24-Hour Ambulatory Blood Pressure Monitoring Study in Hypogonadal Men Receiving Testosterone Replacement Therapy
NCT04274894 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- 24-Hour Ambulatory Blood Pressure Monitoring Study in Hypogonadal Men Receiving Testosterone Replacement Therapy
- Lead sponsor
- AbbVie
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- May 12, 2020
- Completion date
- January 7, 2022
- Enrollment
- 246 (actual)
- Sites
- 45
Conditions
As the registry lists them; a condition with its own page is linked.